Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Color-Doppler ultrasound used to evaluate response to neoadjuvant treatment
June 9th, 2005
Color-Doppler ultrasound (CDU) was used to evaluate response to neoadjuvant treatment in patients with locally advanced breast carcinoma. According to recent research published in the journal Anticancer Research, "The aim of our study was to assess the CDU pattern in the analysis of neoadjuvant preoperative treatment of patients with locally advanced breast carcinoma, improvement after injection of contrast medium (Levovist) and possible correlations between morphological and vascular aspects of the neoplasm and postoperative histopathological findings." "We studied 50 patients affected by locally advanced breast carcinoma (T3a e b-T4), using...
Source: Women's Health Weekly (2005-06-09)
|
